SEC Filings | Olema Oncology

Filing date	Description	Form	View
Sep 21, 2020	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	0001104659-20-106601.pdf 0001104659-20-106601.rtf 0001104659-20-106601.xls View HTML
Mar 03, 2022	Delaying amendment	DEL AM	0001558370-22-002810.pdf 0001558370-22-002810.rtf View HTML
Nov 16, 2020	CORRESP	CORRESP	0001104659-20-125328.pdf 0001104659-20-125328.rtf View HTML
Nov 16, 2020	CORRESP	CORRESP	0001104659-20-125682.pdf 0001104659-20-125682.rtf 0001104659-20-125682.xls View HTML
Nov 16, 2020	CORRESP	CORRESP	0001104659-20-125683.pdf 0001104659-20-125683.rtf 0001104659-20-125683.xls View HTML
Apr 28, 2022	CORRESP	CORRESP	0001558370-22-006312.pdf 0001558370-22-006312.rtf 0001558370-22-006312.xls View HTML
Feb 07, 2024	CORRESP	CORRESP	0000950170-24-012183.pdf 0000950170-24-012183.rtf View HTML
Nov 18, 2020	Certification by an exchange approving securities for listing	CERT	8A_Cert_OLMA.pdf 186.6 KB View HTML
Mar 17, 2021	Annual report which provides a comprehensive overview of the company for the past year	10-K	0001558370-21-003141.pdf 0001558370-21-003141.rtf 0001558370-21-003141.xls View HTML
Feb 28, 2022	Annual report which provides a comprehensive overview of the company for the past year	10-K	0001558370-22-002388.pdf 0001558370-22-002388.rtf 0001558370-22-002388.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.